By Craig Sandstrom and Tom MacKnight
BIOCONTRACT SERVICES:
A Supplement to BPJ Volume 3, Issue 3 (May/June 2004)
The number of mammalian cell-culture based products is increasing rapidly and has the potential to out-pace the current production capacity. New facility construction for mammalian cell culture production is costly and time consuming. Planning for initial product launch and long-term commercial manufacturing can be daunting for promising products in late phase clinical trials…
Citation: Sandstrom C, MacKnight T. Facility Design for Contract Manufacturing. BioProcess J, 2004; 3(3, Suppl. 2): S15-20. https://doi.org/10.12665/BCS2.Sandstrom
Posted online July 19, 2026